Showing results (1811-1820 of 2,227) with videos related to
Sort By:
Pageof 223
Medical and Pediatric Oncology|August 5, 2000
P53 mutation and MDM2 amplification frequency in pediatric rhabdomyosarcoma tumors and cell linesA C Taylor, L Shu, M K Danks, et al.Medical and Pediatric Oncology|August 5, 2000
Sperm and ova conservation: existing standards of practice in North AmericaA Glaser, O Wilkey, M GreenbergMedical and Pediatric Oncology|August 5, 2000
Guidelines for the recognition, prevention, and remediation of burnout in health care professionals participating in the care of children with cancer: report of the SIOP Working Committee on Psychosocial Issues in Pediatric OncologyJ J Spinetta, M Jankovic, M W Ben Arush, et al.Medical and Pediatric Oncology|September 24, 1999
Late complications of therapy in 213 children with localized, nonorbital soft-tissue sarcoma of the head and neck: A descriptive report from the Intergroup Rhabdomyosarcoma Studies (IRS)-II and - III. IRS Group of the Children's Cancer Group and the Pediatric Oncology GroupR B Raney, L Asmar, R Vassilopoulou-Sellin, et al.Medical and Pediatric Oncology|October 26, 1999
Cyclosporine A therapy for multisystem langerhans cell histiocytosisM Minkov, N Grois, V Broadbent, et al.Medical and Pediatric Oncology|November 26, 1999
Radiotherapy of central nervous system tumors in young children: benefits and pitfallsA Skowrońska-GardasMedical and Pediatric Oncology|February 5, 2000
Oral ciprofloxacin vs. intravenous ceftriaxone administered in an outpatient setting for fever and neutropenia in low-risk pediatric oncology patients: randomized prospective trialA S Petrilli, L S Dantas, M C Campos, et al.Medical and Pediatric Oncology|January 1, 1975
Combinations of arabinosyl cytosine and 6-thioguanine for treatment of adults with acute leukemiaG P Bodey, E J Freireich, K B McCredie, et al.Medical and Pediatric Oncology|June 8, 1999
Serum antibody levels and avidities to Escherichia coli O antigens and poliovirus type 1 antigen are increased in children treated for malignant diseaseJ Abrahamsson, B Carlsson, L MellanderMedical and Pediatric Oncology|December 28, 1999
Clinical activity of cisplatin and prolonged oral administration of etoposide in previously treated, anthracycline-resistant, metastatic breast cancer patients: a phase II studyG Fried, M E Stein, N HaimPageof 223